http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
The First Global Management Plan for the Urban Landscape Restructure in Tokyo
Iglesias, Fernando,Shinji, Isoya The Korean Institute of Landscape Architecture 2001 Journal of the Korean institute of landscape archi Vol.1 No.-
The case for study in this paper is the Main Plan and Management for the Fukutoshin; the restructure of Nishi Shinjuku, This plan was first outlines in 1960, and includes a vast area of 96 ha for redevelopment. It aims to create a totally new center in the city. This was the first case in Japan, and in the world of a plan of these magnitudes. involving urban landscape restructuring from three points: Landscape (open spaces for public use: the Shinjuku Central Park and the surrounding area of the buildings), transport and commercial building developments. The Landscape plan for the green areas was decided in a way to compensate the population of the area and the visitors. As a rule, high-rise building constructions are placed each one in single lots and are surrounded by open spaces and greenery. Pedestrain areas are widened and also connected by bridges in a way to allow free circulation, and interconnection between the constructions and the green areas. Another important factor is the role that Private Corporation, and public interest plays. Joining these two forces has allowed the concretization of this project. This interpolation between public and private roles was an innovation in Japan, and it also the key for the concretion of the project. The historical review of the process and management of this project help us to put into perspective the introduction of new concepts and ideas, which were not related at that time to traditional Japanese Landscaping. Furthermore we are better able to understand the substantial increase in the percentage of land dedicated to green areas in contrast to the typical standards of Japanese cities.
O. Iglesias,M. Pazos,M.A. Ferna´ndez de Dios,T. Tavares,M.A. Sanroman 한국공업화학회 2015 Journal of Industrial and Engineering Chemistry Vol.27 No.-
In this work the preparation, characterization and performance of Y-zeolite as catalyst for electro-Fentontreatment of pesticides was carried out. Initially iron supported Y-zeolite (Fe-Y) was prepared andevaluated for the degradation of imidacloprid and chlorpyrifos. Kinetic studies determined that thepesticides removal followed a pseudo-first-order kinetic model. However, the reusability of this catalystwas not appropriated and to enhance its recyclability, Fe-Y catalyst was embedded in alginate (Al-Fe-Y). The new catalyst showed similar degradation efficiency; and the recyclability was improved. This studydemonstrated that Al-Fe-Y could be efficiently used to remove commonly pesticides, imidacloprid andchlorpyrifos, from aqueous medium.
Ignacio Iglesias-Garriz,David Alonso,Carmen Garrote,Victoria Casares,Javier Vara,Jose Maria De la Torre,Miguel A. Rodriguez,Felipe Fernandez-Vazquez 한국심초음파학회 2020 Journal of Cardiovascular Imaging (J Cardiovasc Im Vol.28 No.1
BACKGROUND: Proper scaling of cardiac dimensions is of paramount importance in making correct decisions in clinical cardiology. The usual normalization of cardiac dimensions to overall body size assumes an isometric relationship. We sought to investigate these relationships to obtain the best allometric coefficient (AC) for scaling. METHODS: Ninety-seven healthy volunteers were included. The dimensions to be scaled were the left atrial volume, the end-diastolic and end-systolic left ventricular volumes, and the diameter of the tricuspid annulus. A Bayesian statistical analysis was applied with isometric coefficients as priors. RESULTS: The linear correlations between cardiac dimensions and body size were modest, ranging from 0.12 (-0.10–0.32) for the left atrial volume and height to 0.70 (0.58–0.80) for the end-diastolic volume and height. The ACs varied across the different cardiac dimensions and body size measurements. For the best linear relationships, the isometric coefficients were outside the 95% highest density interval of the posterior distribution for the left atrial volume-weight (AC: 0.7; 0.4–0.9) and end-diastolic volume-height (AC: 2.3; 1.7–2.9), whereas they were different from 1 for the left atrial volume-weight, end-diastolic volume, and diameter of the tricuspid annulus-body surface area (AC: 0.6; 0.3–0.8). Not scaling the cardiac dimensions to their corresponding ACs can lead to important errors in size estimations of cardiac structure. CONCLUSIONS: The ACs found in this study are somewhat different from the corresponding isometric coefficients and often different from 1. This finding should be considered when normalizing cardiac structures to body size when making clinical decisions.
In Vitro Antitumor Properties of an Isolate from Leaves of Cassia alata L
Olarte, Elizabeth Iglesias,Herrera, Annabelle Aliga,Villasenor, Irene Manese,Jacinto, Sonia Donaldo Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.5
Leaf extracts of Cassia alata L (akapulko), traditionally used for treatment of a variety of diseases, were evaluated for their potential antitumor properties in vitro. MTT assays were used to examine the cytotoxic effects of crude extracts on five human cancer cell lines, namely MCF-7, derived from a breast carcinoma, SK-BR-3, another breast carcinoma, T24 a bladder carcinoma, Col 2, a colorectal carcinoma, and A549, a nonsmall cell lung adenocarcinoma. Hexane extracts showed remarkable cytotoxicity against MCF-7, T24, and Col 2 in a dose-dependent manner. This observation was confirmed by morphological investigation using light microscopy. Further bioassay-directed fractionation of the cytotoxic extract led to the isolation of a TLC-pure isolate labeled as f6l. Isolate f6l was further evaluated using MTT assay and morphological and biochemical investigations, which likewise showed selectivity to MCF-7, T24, and Col 2 cells with $IC_{50}$ values of 16, 17, and 17 ${\mu}g/ml$, respectively. Isolate f6l, however, showed no cytotoxicity towards the non-cancer Chinese hamster ovarian cell line (CHO-AA8). Cytochemical investigation using DAPI staining and biochemical investigation using terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)-a method used to detect DNA fragmentation-together with caspase assay, demonstrated apoptotic cell death. Spectral characterization of isolate f6l revealed that it contained polyunsaturated fatty acid esters. Considering the cytotoxicity profile and its mode of action, f6l might represent a new promising compound with potential for development as an anticancer drug with low or no toxicity to non-cancer cells used in this study.
Bone-only oligometastatic prostate cancer: can SABR improve outcomes? A single-center experience
Angel L. Sanchez-Iglesias 대한방사선종양학회 2022 Radiation Oncology Journal Vol.40 No.3
Ablative treatment of oligometastases has shown survival benefit with certain tumors, al-though these effects still are to be demonstrated in prostate cancer. Materials and Methods: We analysed the toxicity and clinical control results obtained in patients withbone-only oligometastatic prostate cancer treated with stereotactic ablative radiotherapy (SABR). Ret-rospective study on patients with metachronous oligoprogression and synchronous de novo bone-onlyoligometastatic prostate cancer treated with SABR and androgen deprivation therapy. Results: Treatment schedules varied according to location and organs at risk, with biologically equiv-alent dose (BED) ≥100 Gy. Fifty-five bone lesions (31 patients) were treated and evaluated for toxicity,local control, progression-free survival (PFS), and overall survival (OS). After a 41-month follow-up,there was minimal acute or chronic toxicity and no G3 toxicity. The local control at 3 and 5 years was100% and 87.1%, respectively. Median PFS and OS were 43 and 98 months, respectively. The best re-sult in PFS was obtained with BED ≥230 Gy, delaying time to the next systemic therapy by 28.5months. Conclusion: The use of SABR in bone oligometastases of prostate cancer is safe with minimal toxicityand excellent results in local control and PFS, delaying the start of the next systemic therapy. Keywords: Stereotactic body radiotherapy, Bone oligometastases, Prostate cancer, Next systemictherapy